SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-000452
Filing Date
2024-01-03
Accepted
2024-01-03 09:11:36
Documents
13
Period of Report
2023-12-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191041-8k_bimiinter.htm   iXBRL 8-K 49452
2 PRESS RELEASE DATED JANUARY 3, 2024 ea191041ex99-1_bimiinter.htm EX-99.1 5331
  Complete submission text file 0001213900-24-000452.txt   232605

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20231229.xsd EX-101.SCH 3009
4 XBRL LABEL FILE bimi-20231229_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bimi-20231229_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea191041-8k_bimiinter_htm.xml XML 3411
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 24504512
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)